Hosted on MSN1mon
Natco Pharma gets nod for generic Everolimus tablets
Natco Pharma Ltd on Thursday said it has received approval from the US health regulator for its generic version of Everolimus tablets for oral suspension indicated for patients with tuberous ...
pharmaphorum12y
Afinitor reduces tumours in rare disease, says Novartis
Novartis has announced that phase 3 clinical trials data published in the Lancet showed significant benefit of its cancer drug, Afinitor (everolimus) in patients with non-cancerous tumours ...